InflaRx N.V. Research and Development Expense
InflaRx N.V. (IFRX) reported Research and Development Expense of EUR 25.72 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-20.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:ResearchAndDevelopmentExpense · last filed 2026-03-20
- InflaRx N.V. research and development expense for the quarter ending 2025-06-30 was 7.20M EUR, a 28.09% decline year-over-year.
- InflaRx N.V. research and development expense for the quarter ending 2024-06-30 was 10.02M EUR, a 8.27% decline year-over-year.
- InflaRx N.V. research and development expense for the quarter ending 2023-06-30 was 10.92M EUR, a 2.34% decline year-over-year.
- InflaRx N.V. research and development expense for the quarter ending 2022-06-30 was 11.18M EUR, a 1.05% decline year-over-year.
EUR
| Period end | Research And Development Expense 3 month | Research And Development Expense 6 month | Research And Development Expense 12 month | Research And Development Expense 12 month as first filed |
|---|---|---|---|---|
| 2025-12-31 | 25.72M EUR 20-F · filed 2026-03-20 | |||
| 2025-06-30 | 7.20M EUR 6-K · filed 2025-08-07 | 14.22M EUR 6-K · filed 2025-08-07 | ||
| 2024-12-31 | 35.36M EUR 20-F · filed 2026-03-20 | |||
| 2024-06-30 | 10.02M EUR 6-K · filed 2025-08-07 | 17.32M EUR 6-K · filed 2025-08-07 | ||
| 2023-12-31 | 41.02M EUR 20-F · filed 2026-03-20 | |||
| 2023-06-30 | 10.92M EUR 6-K · filed 2024-08-08 | 25.65M EUR 6-K · filed 2024-08-08 | ||
| 2022-12-31 | 37.53M EUR 20-F · filed 2025-03-20 | |||
| 2022-06-30 | 11.18M EUR 6-K · filed 2023-08-10 | 21.65M EUR 6-K · filed 2023-08-10 | ||
| 2021-12-31 | 35.70M EUR 20-F · filed 2024-03-21 | |||
| 2021-06-30 | 11.30M EUR 6-K · filed 2022-08-05 | 16.21M EUR 6-K · filed 2022-08-05 | ||
| 2020-12-31 | 25.68M EUR 20-F · filed 2023-03-22 | |||
| 2019-12-31 | 44.58M EUR 20-F · filed 2022-03-24 | |||
| 2019-06-30 | 12.50M EUR 6-K · filed 2019-08-14 | 20.19M EUR 6-K · filed 2019-08-14 | ||
| 2018-12-31 | 25.03M EUR 20-F · filed 2021-03-25 | 25.03M EUR 20-F · filed 2019-03-28 | ||
| 2018-06-30 | 5.03M EUR 6-K · filed 2019-08-14 | 10.51M EUR 6-K · filed 2019-08-14 | ||
| 2017-12-31 | 14.41M EUR 20-F · filed 2020-04-29 | 14.41M EUR 20-F · filed 2018-03-29 | ||
| 2016-12-31 | 5.28M EUR 20-F/A · filed 2019-03-29 | |||
| 2015-12-31 | 3.48M EUR 20-F · filed 2018-03-29 |
USD
| Period end | Research And Development Expense 12 month |
|---|---|
| 2021-12-31 | $35.70M 20-F · filed 2022-03-24 |